Tasigna 200mg - Anticancer drugs | view uses, side effects and price | MHP
NILOTINIB 200MG DESCRIPTION Nilotinib sold under the brand name Tasigna 200mg and its belongs to targeted cancer cells Tasigna 200mg tablet is anticancer drugs, which prohibits development of the cancer cells. Tasigna 200mg tablet is a prescription medicine, which sold under the supervision of medical oncologist. Tasigna 200mg tablet is also belongs to the class of kinase inhibitors. TASIGNA 200mg TASIGNA INDICATION Tasigna 200mg tablet is mainly indicated in the conditions like; Chronic and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included Imatinib in adult patients MECHANISM OF ACTION CML: chronic myelogenous leukemia is caused by BCR-ABL oncogene Tasigna 200mg (nilotinib) is a kinase inhibitor, which prohibits BCR-ABL kinase activity. Tasigna 200mg link to the ATP-bounding site of BCR-ABL protein Tasigna 200mg tablet inhibits proliferation of murine leukemi